[go: up one dir, main page]

NO994250L - Cash (Caspase-homolog) med "dödseffektor" domene, modulatorer av funksjonen til FAS-reseptorer - Google Patents

Cash (Caspase-homolog) med "dödseffektor" domene, modulatorer av funksjonen til FAS-reseptorer

Info

Publication number
NO994250L
NO994250L NO994250A NO994250A NO994250L NO 994250 L NO994250 L NO 994250L NO 994250 A NO994250 A NO 994250A NO 994250 A NO994250 A NO 994250A NO 994250 L NO994250 L NO 994250L
Authority
NO
Norway
Prior art keywords
cash
modulators
domain
function
death effect
Prior art date
Application number
NO994250A
Other languages
English (en)
Norwegian (no)
Other versions
NO994250D0 (no
Inventor
David Wallach
Yura Goltsev
Andrei Kovalenko
Eugene Varfolomeev
Vadim Brodianski
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL12036797A external-priority patent/IL120367A0/xx
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of NO994250D0 publication Critical patent/NO994250D0/no
Publication of NO994250L publication Critical patent/NO994250L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C12N9/6475—Interleukin 1-beta convertase-like enzymes (3.4.22.10; 3.4.22.36; 3.4.22.63)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO994250A 1997-03-03 1999-09-02 Cash (Caspase-homolog) med "dödseffektor" domene, modulatorer av funksjonen til FAS-reseptorer NO994250L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL12036797A IL120367A0 (en) 1997-03-03 1997-03-03 Modulators of the function of FAS receptors and other proteins
IL12075997A IL120759A0 (en) 1997-03-03 1997-05-01 Modulators of the function of fas receptors and other proteins
PCT/IL1998/000098 WO1998039435A1 (en) 1997-03-03 1998-02-26 Cash (caspase homologue) with death effector domain, modulators of the function of fas receptors

Publications (2)

Publication Number Publication Date
NO994250D0 NO994250D0 (no) 1999-09-02
NO994250L true NO994250L (no) 1999-11-02

Family

ID=26323378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994250A NO994250L (no) 1997-03-03 1999-09-02 Cash (Caspase-homolog) med "dödseffektor" domene, modulatorer av funksjonen til FAS-reseptorer

Country Status (19)

Country Link
US (1) US7419804B2 (zh)
EP (1) EP0977842A1 (zh)
JP (1) JP2002500508A (zh)
KR (1) KR100544776B1 (zh)
CN (1) CN1148446C (zh)
AU (1) AU740223B2 (zh)
BG (1) BG64799B1 (zh)
BR (1) BR9808173A (zh)
CA (1) CA2281484A1 (zh)
EA (1) EA003269B1 (zh)
EE (1) EE9900384A (zh)
HK (1) HK1024508A1 (zh)
HU (1) HUP0000913A3 (zh)
IL (3) IL120759A0 (zh)
NO (1) NO994250L (zh)
NZ (1) NZ337143A (zh)
PL (1) PL193394B1 (zh)
SK (1) SK117599A3 (zh)
WO (1) WO1998039435A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19713393C2 (de) * 1997-04-01 2002-12-05 Apotech Res & Dev Ltd Flip-Gen und Flip-Protein
DE19713434C1 (de) * 1997-04-01 1998-09-24 Deutsches Krebsforsch Protein zur Inhibierung von Apoptose
EP1097226A1 (en) * 1998-07-08 2001-05-09 Merck Frosst Canada & Co. Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex
AU2222000A (en) * 1998-12-31 2000-07-31 St. Jude Children's Research Hospital A tumor suppressor protein involved in death signaling, and diagnostics, therapeutics, and screening based on this protein
US7052834B1 (en) 1998-12-31 2006-05-30 St. Jude Children's Research Hospital Tumor suppressor protein involved in death signaling, and diagnostics, therapeutics, and screening based on this protein
US20020174450A1 (en) * 2000-12-11 2002-11-21 Allen Keith D. Transgenic mice containing cash gene disruptions
CN110988354A (zh) * 2019-11-15 2020-04-10 同济大学 一种分泌蛋白Caspase1在早期心梗诊断试剂中的应用
CN116426678B (zh) * 2023-03-27 2024-03-22 中国热带农业科学院三亚研究院 与番木瓜果肉果糖含量相关的snp分子标记及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114615A0 (en) 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
EP0841399A3 (en) * 1996-11-12 1998-07-08 Smithkline Beecham Corporation Mammalian fin-1 nucleic acid (a caspase) and protein sequences and uses therefor
JP2001511011A (ja) * 1997-01-21 2001-08-07 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド 腫瘍壊死因子レセプター−１誘導性アポトーシスおよびｃｄ−９５誘導性アポトーシスの新規なインヒビターである、ｉ−ｆｌｉｃｅ
US6242569B1 (en) * 1997-02-05 2001-06-05 Tularik, Inc. Regulators of apoptosis
DE19713393C2 (de) 1997-04-01 2002-12-05 Apotech Res & Dev Ltd Flip-Gen und Flip-Protein
US6207458B1 (en) * 1998-05-07 2001-03-27 University Of Washigton/Stowers Insitute For Medical Research Proteins capable of regulating NF-κB JNK and apoptosis pathways and methods of using the same

Also Published As

Publication number Publication date
BR9808173A (pt) 2000-05-16
KR100544776B1 (ko) 2006-01-23
US20060216788A1 (en) 2006-09-28
PL193394B1 (pl) 2007-02-28
CN1148446C (zh) 2004-05-05
JP2002500508A (ja) 2002-01-08
CA2281484A1 (en) 1998-09-11
AU740223B2 (en) 2001-11-01
WO1998039435A1 (en) 1998-09-11
EA003269B1 (ru) 2003-02-27
HUP0000913A2 (hu) 2000-06-28
KR20000075721A (ko) 2000-12-26
HUP0000913A3 (en) 2001-11-28
NZ337143A (en) 2001-12-21
US7419804B2 (en) 2008-09-02
EE9900384A (et) 2000-04-17
EP0977842A1 (en) 2000-02-09
CN1249780A (zh) 2000-04-05
IL131247A (en) 2007-08-19
IL131247A0 (en) 2001-01-28
IL120759A0 (en) 1997-09-30
EA199900794A1 (ru) 2000-04-24
NO994250D0 (no) 1999-09-02
SK117599A3 (en) 2000-05-16
PL335448A1 (en) 2000-04-25
HK1024508A1 (en) 2000-10-13
BG103693A (en) 2000-05-31
AU6112698A (en) 1998-09-22
BG64799B1 (bg) 2006-04-28

Similar Documents

Publication Publication Date Title
DE69624072D1 (de) Wegwerfschutzmaske
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
DE69605903D1 (de) Verriegelungskupplung
DE69625233D1 (de) Einrichtung vom flipchiptyp
DE69609822D1 (de) Schutzvliesschichtstoff
DE69816443D1 (de) Sicherheitsspritze
DE69604690D1 (de) Sicherheitssitz
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
DE69812708D1 (de) Neue arzneimittel enthaltend uridintriphosphat
DE69836697D1 (de) Neue 3,6-Hemiketale der 9a-Azalidklasse
IT1304008B1 (it) Dispositivo per l'eliminazione di ratti e simili.
NO994250L (no) Cash (Caspase-homolog) med "dödseffektor" domene, modulatorer av funksjonen til FAS-reseptorer
DE69614897D1 (de) Sicherheitsverschluss
PT964867E (pt) Antagonistas da taquicinima
DE69611758D1 (de) N-1-carbocylalkyl derivate von lsd
FR2786345B1 (fr) Dispositif de cryptage quantique
NO953050L (no) Anvendelse av neurotensin-antagonister for fremstilling av diuretiske medikamenter
FR2762366B1 (fr) Dispositif d'assemblage, notamment pour meubles
Flinterman The protection of economic, social and cultural rights and the European Convention on Human Rights
FI953081A (fi) Sekviterpeenit, niiden valmistaminen ja niiden käyttö inhibiittoreina, jotka vaikuttavat GABA-bentsodiatsepiinireseptoriin
FI904391A0 (fi) Belaeggning foer behandlingsorgan vid en maskin foer behandling av rot- och rotknoelfrukter.
FR2757582B1 (fr) Dispositif d'assemblage de securite
DE19581941T1 (de) Pflug
KR970036125U (ko) 아웃사이드 미러의 동결 방지장치
KR970050187U (ko) 지폐의 강제역송 차단잠금장치

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application